BOSTON - Prosecutors on Thursday will present their closing arguments in the trial of the wealthy founder of pharmaceutical company Insys Therapeutics Inc and four colleagues accused of contributing to the U.S. opioid epidemic by bribing doctors to prescribe an addictive fentanyl spray.
Prosecutors say Kapoor oversaw a wide-ranging scheme to bribe doctors nationwide by retaining them to act as speakers at poorly-attended sham events at restaurants ostensibly meant to educate clinicians about its fentanyl spray, Subsys. All five have pleaded not guilty to racketeering conspiracy. Lawyers for Kapoor acknowledge that Insys paid doctors but contend that he believed they really were being paid to talk up the product’s benefits.